NCT05779930 2025-08-15
Safety and Feasibility of CD19 CAR T Cells Using CliniMACS Prodigy for Relapsed/Refractory CD19 Positive ALL and NHL
Nationwide Children's Hospital
Phase EARLY_PHASE1 Not yet recruiting
Clinical Trials
1 trialsPhase EARLY_PHASE1 × Not yet recruiting × Precursor Cell Lymphoblastic Leukemia-Lymphoma × Clear all